Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
Clinical trial NCT00083096 · UNKNOWN
Trial details
- NCT number
- NCT00083096
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2009-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.